1,611
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium

, , , , &
Pages 1245-1254 | Received 15 Jul 2016, Accepted 14 Feb 2017, Published online: 24 Mar 2017

References

  • Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013; 9:e1003418; PPATHOGENS-D-13-00807 [pii]; PMID:23935481; http://dx.doi.org/10.1371/journal.ppat.1003418
  • He Q, Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol 2008; 3:329-39; PMID:18505398; http://dx.doi.org/10.2217/17460913.3.3.329
  • Superior Health Council (2013) https://www.zorg-en-gezondheid.be/sites/default/files/atoms/files/vaccinatie_fiche_volw_kinkhoest_20130830.pdf
  • Maertens K, Cabore RN, Huygen K, Hens N, Van DP, Leuridan E. Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study 2. Vaccine 2016; 34:142-50; S0264-410X(15)01556-X [pii]; PMID:26592142; http://dx.doi.org/10.1016/j.vaccine.2015.10.100
  • Maertens K, Cabore RN, Huygen K, Vermeiren S, Hens N, Van DP, Leuridan E. Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age. Vaccine 2016; 34:3613-9; S0264-410X(16)30231-6 [pii]; PMID:27142328; http://dx.doi.org/10.1016/j.vaccine.2016.04.066
  • Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis 2013; 56:1458-65; cit048 [pii]; PMID:23386629; http://dx.doi.org/10.1093/cid/cit048
  • Poolman J, Kaufhold A, De GD, Goldblatt D. Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine 2001; 19:2280-5; S0264410×0000517X [pii]; PMID:11257348; http://dx.doi.org/10.1016/S0264-410X(00)00517-X
  • Denoel PA, Goldblatt D, De V, I, Jacquet JM, Pichichero ME, Poolman JT. Quality of the Haemophilus influenzae type b (Hib) antibody response induced by diphtheria-tetanus-acellular pertussis/Hib combination vaccines. Clin Vaccine Immunol 2007; 14:1362-9. CVI.00154-07 [pii]; PMID:17699836; http://dx.doi.org/10.1128/CVI.00154-07
  • Dimitrov JD, Lacroix-Desmazes S, Kaveri SV. Important parameters for evaluation of antibody avidity by immunosorbent assay. Anal Biochem 2011; 418:149-51; S0003-2697(11)00461-1 [pii]; PMID:21803020; http://dx.doi.org/10.1016/j.ab.2011.07.007
  • Marchant A, Pihlgren M, Goetghebuer T, Weiss HA, Ota MO, Schlegel-Hauter SE, Whittle H, Lambert PH, Newport MJ, Siegrist CA. Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infants. J Infect Dis 2006; 193:1598-605; JID35412 [pii]; PMID:16652290; http://dx.doi.org/10.1086/503775
  • Yu YH, Lin KI. Factors that regulate the generation of antibody-secreting plasma cells. Adv Immunol 2016; 131:61-99; S0065-2776(16)30020-7 [pii]; PMID:27235681
  • French DL, Laskov R, Scharff MD. The role of somatic hypermutation in the generation of antibody diversity. Science 1989; 244:1152-7; PMID:2658060; http://dx.doi.org/10.1126/science.2658060
  • Goldblatt D, Vaz AR, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 1998; 177:1112-5; PMID:9534995; http://dx.doi.org/10.1086/517407
  • Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009; 9:185-94; nri2508 [pii]; PMID:19240757; http://dx.doi.org/10.1038/nri2508
  • Matos DC, Silva AM, Neves PC, Martins RM, Homma A, Marcovistz R. Pattern of functional antibody activity against Haemophilus influenzae type B (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine. Braz J Med Biol Res 2009; 42:1242-7; S0100-879×2009005000039 [pii]; PMID:19893995; http://dx.doi.org/10.1590/S0100-879X2009005000039
  • Lieberman JM, Greenberg DP, Wong VK, Partridge S, Chang SJ, Chiu CY, Ward JI. Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines. J Pediatr 1995; 126:198-205; S0022-3476(95)70545-7 [pii]; PMID:7844665; http://dx.doi.org/10.1016/S0022-3476(95)70545-7
  • Prince HE, Lieberman JM, Cherry JD. Age-related differences in patterns of increased Bordetella pertussis antibodies. Clin Vaccine Immunol 2012; 19:545-50; CVI.05725-11 [pii]; PMID:22357646; http://dx.doi.org/10.1128/CVI.05725-11
  • Marchant A, Kollmann TR. Understanding the ontogeny of the immune system to promote immune-mediated health for life. Front Immunol 2015; 6:77; PMID:25755655; http://dx.doi.org/10.3389/fimmu.2015.00077
  • Schallert N, Pihlgren M, Kovarik J, Roduit C, Tougne C, Bozzotti P, Del GG, Siegrist CA, Lambert PH. Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccines. Eur J Immunol 2002; 32:752-60; PMID:11870619; http://dx.doi.org/10.1002/1521-4141
  • Almanzar G, Ottensmeier B, Liese J, Prelog M. Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate. J Immunol Methods 2013; 387:36-42; S0022-1759(12)00290-6 [pii]; PMID:23022630; http://dx.doi.org/10.1016/j.jim.2012.09.008
  • Prelog M, Almanzar G, Rieber N, Ottensmeier B, Zlamy M, Liese J. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination. Vaccine 2013; 31:387-93; S0264-410X(12)01578-2 [pii]; PMID:23142306; http://dx.doi.org/10.1016/j.vaccine.2012.10.105
  • Abu RB, Bamberger E, Almog M, Peri R, Srugo I, Kessel A. Immunization of pregnant women against pertussis: the effect of timing on antibody avidity. Vaccine 2015; 33:1948-52; S0264-410X(15)00248-0 [pii]; PMID:25744227; http://dx.doi.org/10.1016/j.vaccine.2015.02.059
  • Barkoff AM, Grondahl-Yli-Hannuksela K, Vuononvirta J, Mertsola J, Kallonen T, He Q. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection. Vaccine 2012; 30:6897-902; S0264-410X(12)01302-3 [pii]; PMID:22981763; http://dx.doi.org/10.1016/j.vaccine.2012.09.003
  • Ibrahim NM, El-Kady EM, Eissa SA, Wahby AF. Assessment of antibody level and avidity against Bordetella pertussis in a cohort of Egyptian individuals aged 1–18 years 1. J Adv Res 2016; 7:105-11; S2090-1232(15)00032-6 [pii]; PMID:26843976; http://dx.doi.org/10.1016/j.jare.2015.03.002
  • Aboud S, Matre R, Lyamuya EF, Kristoffersen EK. Levels and avidity of antibodies to tetanus toxoid in children aged 1–15 years in Dar es Salaam and Bagamoyo, Tanzania. Ann Trop Paediatr 2000; 20:313-22; PMID:11219170; http://dx.doi.org/10.1080/02724936.2000.11748153
  • Maertens K, Hoang TH, Cabore RN, Leuridan E. Avidity of maternal pertussis antibodies after vaccination during pregnancy. Vaccine 2015; 33(42):5489; S0264-410X(15)00748-3 [pii].
  • Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Vaccine 2009; 27:6530-6; S0264-410X(09)01237-7 [pii]; PMID:19729085; http://dx.doi.org/10.1016/j.vaccine.2009.08.052
  • Andersson U, Bird G, Britton S. A sequential study of human B lymphocyte function from birth to two years of age 313. Acta Paediatr Scand 1981; 70:837-42; PMID:6275657; http://dx.doi.org/10.1111/j.1651-2227.1981.tb06236.x
  • Stenger RM, Smits M, Kuipers B, Kessen SF, Boog CJ, van Els CA. Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens. Clin Vaccine Immunol 2011; 18:595-603; CVI.00061-10 [pii]; PMID:21325488; http://dx.doi.org/10.1128/CVI.00061-10
  • Abu RB, Srugo I, Bamberger E, Kessel A. The avidity of pertussis antibodies following gestational acellular pertussis immunization: Reply to Maertens. Vaccine 2015; 33(42):5490-1; S0264-410X(15)00763-X [pii].
  • Eberhardt CS, Blanchard-Rohner G, Lemaitre B, Boukrid M, Combescure C, Othenin-Girard V, Chilin A, Petre J, de Tejada BM, Siegrist CA. Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis 2. Clin Infect Dis 2016; 62:829-36. ciw027 [pii]; PMID:26797213; http://dx.doi.org/10.1093/cid/ciw027
  • Abu RB, Srugo I, Bamberger E. Optimal timing of immunization against pertussis during pregnancy 1. Clin Infect Dis 2016; 63(1):143-4; ciw233 [pii].
  • Siegrist CA. Neonatal and early life vaccinology. Vaccine 2001; 19:3331-46; S0264410×01000287 [pii]; PMID:11348697; http://dx.doi.org/10.1016/S0264-410X(01)00028-7
  • Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014; 311:1760-9; 1866102 [pii]; PMID:24794369; http://dx.doi.org/10.1001/jama.2014.3633
  • Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis 2015; 61:1637-44. civ695 [pii]; PMID:26374816; http://dx.doi.org/10.1093/cid/civ695
  • Hardy-Fairbanks AJ, Pan SJ, Decker MD, Johnson DR, Greenberg DP, Kirkland KB, Talbot EA, Bernstein HH. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013; 32:1257-60; PMID:23799518; http://dx.doi.org/10.1097/INF.0b013e3182a09b6a
  • Scheifele DW, Ochnio JJ. The Immunological Basis for Immunization Series/ Module 2: Diphtheria Update 2009. [pp.1-128]; WHO.
  • Booy R, Aitken SJ, Taylor S, Tudor-Williams G, Macfarlane JA, Moxon ER, Ashworth LA, Mayon-White RT, Griffiths H, Chapel HM. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet 1992; 339:507-10; 0140–6736(92)90336-2 [pii]; PMID:1346876; http://dx.doi.org/10.1016/0140-6736(92)90336-2
  • Tiru M, Hallander HO, Gustafsson L, Storsaeter J, Olin P. Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster. Vaccine 2000; 18:2295-306; S0264-410X(99)00539-3 [pii]; PMID:10717350; http://dx.doi.org/10.1016/S0264-410X(99)00539-3
  • Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-van Spaendonck MA, Hallander HO, Olander R, Maple PA, Melker HE, et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect 2000; 125:113-25; PMID:11057967; http://dx.doi.org/10.1017/S0950268899004161
  • Huygen K. Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use? Virulence 2016; 7:613-5; PMID:27196732; http://dx.doi.org/10.1080/21505594.2016.1190062
  • European Centre for Disease Prevention and Control. A fatal case of diphtheria in Belgium 2016. 24 March 2016: ECDC; 2016. http://ecdc.europa.eu/en/publications/Publications/RRA-Diphtheria-Belgium.pdf
  • ACOG Committee Opinion No. 566: Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Obstet Gynecol 2013; 121:1411-4; 00006250-201306000-00044 [pii]; PMID:23812487; http://dx.doi.org/10.1097/01.AOG.0000431054.33593.e3
  • Storsaeter J, Hallander HO, Gustafsson L, Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 1998; 16:1907-16; S0264410×98002278 [pii]; PMID:9796042; http://dx.doi.org/10.1016/S0264-410X(98)00227-8
  • Taranger J, Trollfors B, Lagergard T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 2000; 181:1010-3; JID990862 [pii]; PMID:10720524; http://dx.doi.org/10.1086/315318
  • Heininger U, Riffelmann M, Bar G, Rudin C, von Konig CH. The protective role of maternally derived antibodies against Bordetella pertussis in young infants. Pediatr Infect Dis J 2013; 32:695-8; PMID:23429559; http://dx.doi.org/10.1097/INF.0b013e318288b610

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.